23-Feb-2026
Download PDF
Anthem Biosciences
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation 2025 we hereby inform that the Company has executed on February 23 2026 First amendment to the Loan agreement dated April 15 2024 entered with Neoanthem Lifesciences Private Limited (Wholly Owned Subsidiary).
Disclaimer: This content is for information only and should not be considered investment advice or a recommendation.
For grievances: [email protected]
Ask Value Research 
Widely read:
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
